Hangzhou Copel Chemical Co., Ltd. is located in the beautiful city, Hangzhou City. Hangzhou Copel Chemical Co., Ltd. (Hereinafter referred to as”Copel”) is a professional supplier on APIs,pharmaceutical intermediates, excipients & food additives and Veterinary in China. Mean while,We here emphasize we are very strong on contract manufacturing.
Copel has developed stable strategic cooperation with many good manufacturers in China. Specially we have good contracted sources.
Copel has exported varieties of products to different markets. Our products and professional service are highly satisfied by the customers.
On March 2, the US FDA has approved a new drug application (NDA) for AZSTARYS (code name: KP415), once a day, for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years and older. Will be commercialized in the United States. To
AZSTARYS is a compound capsule dosage form composed of dexmethylphenidate (d-MPH) prodrug serdexmethylphenidate (SDX) and immediate release d-MPH. AZSTARYS contains 30% immediate release d-MPH and 70% extended release new SDX. After being absorbed through the gastrointestinal tract, SDX is converted to d-MPH, and d-MPH is gradually released within a day.
Compared with the currently marketed drugs Vyvanse (Ridexamphetamine Dimesylate Capsules) and Osmotic (Methylphenidate Hydrochloride Sustained Release Tablets), AZSTARYS has the advantage of immediate onset due to the immediate release of d-MPH. Compared with Adderall XR (amphetamine complex salt sustained-release capsules) and Focalin XR (dexmethylphenidate hydrochloride sustained-release capsules), because SDX is a prodrug, it can reduce drug dependence.